Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.
Launched by GOETHE UNIVERSITY · Jun 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of robot-assisted surgery for a procedure called radical cystectomy, which involves removing the bladder, and possibly reconstructing it. The researchers want to find out how this type of surgery affects blood loss, pain levels, and the need for blood transfusions in patients. The goal is to understand if using robotic technology can make the surgery safer and more comfortable for patients.
To participate in this trial, you should be between the ages of 65 and 74 and have a planned radical cystectomy. However, if you have a severe health condition or a known blood clotting disorder, you won’t be eligible. If you join the study, you can expect to be monitored closely for your blood loss and pain after the surgery, and researchers will track whether you need any blood transfusions. This information could help improve future treatments for patients undergoing bladder surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • planned radical cystectomy
- Exclusion Criteria:
- • ASA classification V
- • Previously known coagulation disorder
About Goethe University
Goethe University, located in Frankfurt, Germany, is a prestigious academic institution renowned for its commitment to research excellence and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, Goethe University leverages its robust interdisciplinary resources and expertise to advance medical research and improve patient outcomes. The university fosters collaboration among faculty, researchers, and healthcare professionals to design and conduct rigorous clinical trials, ensuring adherence to ethical standards and regulatory requirements. Through its dedication to scientific inquiry and public health, Goethe University plays a pivotal role in translating research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported